TrialActa ophthalmologica2026

Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4.

Helena M A Feenstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.